1 | plaque | 4,820 |
2 | colony | 806 |
3 | follicle | 683 |
4 | atheroma | 357 |
5 | fibroid | 168 |
6 | bleb | 157 |
7 | drusen | 138 |
8 | plaque-type | 62 |
9 | tophus | 31 |
10 | macrophage-colony | 25 |
11 | cd64 | 14 |
12 | comedonal | 14 |
13 | nodulocystic | 9 |
14 | postprocess | 7 |
15 | enthesis | 6 |
16 | heat-dampness | 6 |
17 | nanoplaque | 6 |
18 | p+m | 6 |
19 | ca2+3 | 5 |
20 | mibelli | 5 |
21 | right/left-volume | 5 |
22 | lung-volume | 4 |
23 | ndmp | 4 |
24 | s-nitrosothiol | 4 |
25 | 'percent | 3 |
26 | caries-lesion | 3 |
27 | chlamydospore | 3 |
28 | freckle | 3 |
29 | low-tumor | 3 |
30 | sdgm | 3 |
31 | subvolume | 3 |
32 | tidemark | 3 |
33 | urea5 | 3 |
34 | /af | 2 |
35 | 1,4,5-ip3 | 2 |
36 | 3,132 | 2 |
37 | 5-hydroxy-3-methoxyxanthone | 2 |
38 | 7bl | 2 |
39 | aß42 | 2 |
40 | bone-mass | 2 |
41 | erythropoesis | 2 |
42 | finasteride-induced | 2 |
43 | granulocyte/macrophage-colony | 2 |
44 | non-carcinogens | 2 |
45 | over-immunosuppression | 2 |
46 | photo-electron | 2 |
47 | scorpionic | 2 |
48 | -1-octen-3-ol | 1 |
49 | -γ-melanocyte | 1 |
50 | alpha-hemoglobin | 1 |
51 | angiopathy-related | 1 |
52 | atomic-layer | 1 |
53 | clony | 1 |
54 | coxsackievirus-induced | 1 |
55 | events.’ | 1 |
56 | extinction-learning | 1 |
57 | hibh | 1 |
58 | histaminedihydrochloride | 1 |
59 | inner-glove | 1 |
60 | lesion+topical | 1 |
61 | microbical | 1 |
62 | ofgonadotropin | 1 |
63 | oligosaccharide-based | 1 |
64 | phases-hematoma | 1 |
65 | pma/calcium | 1 |
66 | ripc/isoflurane | 1 |
67 | rsv-proven | 1 |
68 | s-protein | 1 |
69 | trials.disability | 1 |
70 | volume/vessel | 1 |
71 | ×two | 1 |
72 | κb/rel | 1 |
1 | 'percent | 3 |
2 | -1-octen-3-ol | 1 |
3 | -γ-melanocyte | 1 |
4 | /af | 2 |
5 | 1,4,5-ip3 | 2 |
6 | 3,132 | 2 |
7 | 5-hydroxy-3-methoxyxanthone | 2 |
8 | 7bl | 2 |
9 | alpha-hemoglobin | 1 |
10 | angiopathy-related | 1 |
11 | atheroma | 357 |
12 | atomic-layer | 1 |
13 | aß42 | 2 |
14 | bleb | 157 |
15 | bone-mass | 2 |
16 | ca2+3 | 5 |
17 | caries-lesion | 3 |
18 | cd64 | 14 |
19 | chlamydospore | 3 |
20 | clony | 1 |
21 | colony | 806 |
22 | comedonal | 14 |
23 | coxsackievirus-induced | 1 |
24 | drusen | 138 |
25 | enthesis | 6 |
26 | erythropoesis | 2 |
27 | events.’ | 1 |
28 | extinction-learning | 1 |
29 | fibroid | 168 |
30 | finasteride-induced | 2 |
31 | follicle | 683 |
32 | freckle | 3 |
33 | granulocyte/macrophage-colony | 2 |
34 | heat-dampness | 6 |
35 | hibh | 1 |
36 | histaminedihydrochloride | 1 |
37 | inner-glove | 1 |
38 | lesion+topical | 1 |
39 | low-tumor | 3 |
40 | lung-volume | 4 |
41 | macrophage-colony | 25 |
42 | mibelli | 5 |
43 | microbical | 1 |
44 | nanoplaque | 6 |
45 | ndmp | 4 |
46 | nodulocystic | 9 |
47 | non-carcinogens | 2 |
48 | ofgonadotropin | 1 |
49 | oligosaccharide-based | 1 |
50 | over-immunosuppression | 2 |
51 | p+m | 6 |
52 | phases-hematoma | 1 |
53 | photo-electron | 2 |
54 | plaque | 4,820 |
55 | plaque-type | 62 |
56 | pma/calcium | 1 |
57 | postprocess | 7 |
58 | right/left-volume | 5 |
59 | ripc/isoflurane | 1 |
60 | rsv-proven | 1 |
61 | s-nitrosothiol | 4 |
62 | s-protein | 1 |
63 | scorpionic | 2 |
64 | sdgm | 3 |
65 | subvolume | 3 |
66 | tidemark | 3 |
67 | tophus | 31 |
68 | trials.disability | 1 |
69 | urea5 | 3 |
70 | volume/vessel | 1 |
71 | ×two | 1 |
72 | κb/rel | 1 |
1 | 3,132 | 2 |
2 | aß42 | 2 |
3 | ca2+3 | 5 |
4 | 1,4,5-ip3 | 2 |
5 | cd64 | 14 |
6 | urea5 | 3 |
7 | atheroma | 357 |
8 | phases-hematoma | 1 |
9 | bleb | 157 |
10 | scorpionic | 2 |
11 | nodulocystic | 9 |
12 | finasteride-induced | 2 |
13 | coxsackievirus-induced | 1 |
14 | oligosaccharide-based | 1 |
15 | angiopathy-related | 1 |
16 | fibroid | 168 |
17 | histaminedihydrochloride | 1 |
18 | follicle | 683 |
19 | freckle | 3 |
20 | lung-volume | 4 |
21 | right/left-volume | 5 |
22 | subvolume | 3 |
23 | ripc/isoflurane | 1 |
24 | 5-hydroxy-3-methoxyxanthone | 2 |
25 | plaque-type | 62 |
26 | chlamydospore | 3 |
27 | -γ-melanocyte | 1 |
28 | plaque | 4,820 |
29 | nanoplaque | 6 |
30 | inner-glove | 1 |
31 | /af | 2 |
32 | extinction-learning | 1 |
33 | hibh | 1 |
34 | mibelli | 5 |
35 | tidemark | 3 |
36 | microbical | 1 |
37 | lesion+topical | 1 |
38 | comedonal | 14 |
39 | 7bl | 2 |
40 | κb/rel | 1 |
41 | volume/vessel | 1 |
42 | -1-octen-3-ol | 1 |
43 | s-nitrosothiol | 4 |
44 | p+m | 6 |
45 | sdgm | 3 |
46 | pma/calcium | 1 |
47 | drusen | 138 |
48 | rsv-proven | 1 |
49 | alpha-hemoglobin | 1 |
50 | s-protein | 1 |
51 | ofgonadotropin | 1 |
52 | caries-lesion | 3 |
53 | over-immunosuppression | 2 |
54 | photo-electron | 2 |
55 | ×two | 1 |
56 | ndmp | 4 |
57 | atomic-layer | 1 |
58 | low-tumor | 3 |
59 | enthesis | 6 |
60 | erythropoesis | 2 |
61 | non-carcinogens | 2 |
62 | bone-mass | 2 |
63 | postprocess | 7 |
64 | heat-dampness | 6 |
65 | tophus | 31 |
66 | 'percent | 3 |
67 | clony | 1 |
68 | colony | 806 |
69 | macrophage-colony | 25 |
70 | granulocyte/macrophage-colony | 2 |
71 | trials.disability | 1 |
72 | events.’ | 1 |